ABCG2 and neoplasm: This hypothesis warrants further investigation; identification of miRNA binding sites in the 3' UTR of genes such as ABCG2 that promote multidrug resistance could enable the delivery of specific miRNAs from this cluster to tumours in an attempt to repress ABCG2 and to increase sensitivity to existing therapeutic agents.